Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial

Objective: To evaluate the safety and efficacy of golimumab + methotrexate (MTX) in Japanese patients with active rheumatoid arthritis (RA). Methods: Japanese patients with active RA despite MTX were randomized to placebo + MTX (Group 1, n = 88), golimumab 50 mg + MTX (Group 2, n = 86), or golimumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mod Rheumatol
Main Authors: Tanaka, Yoshiya, Harigai, Masayoshi, Takeuchi, Tsutomu, Yamanaka, Hisashi, Ishiguro, Naoki, Yamamoto, Kazuhiko, Miyasaka, Nobuyuki, Koike, Takao, Baker, Daniel, Ishii, Yutaka, Yoshinari, Toru
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924564/
https://ncbi.nlm.nih.gov/pubmed/26474192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14397595.2015.1109762
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados